Under the definitive merger agreement, which was unanimously approved by both companies’ board of directors, CHS will pay Health Management $3.9 billion in cash and stock. CHS valued Health Management’s stock at $13.78 per share. CHS will also assume $3.7 billion of Health Management’s debt.
Continue on to full article.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.